Tri-Lo-Sprintec (Teva Pharmaceuticals USA, Inc.)
Welcome to the PulseAid listing for the Tri-Lo-Sprintec drug offered from Teva Pharmaceuticals USA, Inc.. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Teva Pharmaceuticals USA, Inc. |
NON-PROPRIETARY NAME: | Norgestimate and Ethinyl Estradiol |
SUBSTANCE NAME: | |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | |
ROUTE: | |
DOSAGE FORM: | KIT |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2015-12-30 |
END MARKETING DATE: | 0000-00-00 |
Tri-Lo-Sprintec HUMAN PRESCRIPTION DRUG Details:
Item Description | Tri-Lo-Sprintec from Teva Pharmaceuticals USA, Inc. |
LABELER NAME: | Teva Pharmaceuticals USA, Inc. |
DEA SCHEDULE: | |
ACTIVE STRENGTH: | () |
START MARKETING DATE: | 2015-12-30 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0093-2140_5c6d5f13-e1ed-4e64-8858-a02244d71af1 |
PRODUCT NDC: | 0093-2140 |
APPLICATION NUMBER: | ANDA076784 |